Andrew Philip Platt

Dr. Andrew Philip Platt


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2022 in Nature
Verified
Journal Article
Open access
PDF file
SSSydney R. Stein
Sydney R. Stein
SRSabrina C. Ramelli
Sabrina C. Ramelli
AGAlison Grazioli
Alison Grazioli
Joon-Yong ChungJoon-Yong Chung
Joon-Yong Chung
MSManmeet Singh
Manmeet Singh
DCDaniel S. Chertow
Daniel S. Chertow
Coronavirus disease 2019 (COVID-19) is known to cause multi-organ dysfunction1,2,3 during acute infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with some patients experiencing prolonged symptoms, termed post-acute sequelae of SARS-CoV-2 (refs. 4,5). However, the burden of infection outside the respiratory tract and time to viral clearance are not well characterized, particularly in the brain3,6,7,8,9,10,11,12,13,14. Here we carried out complete autopsies on 44 patients who died with COVID-19, with extensive sampling of the central nervous system in 11 of these patients, to map and quantify the distribution, replication and cell-type specificity of SARS-CoV-2 across the human body, including the brain, from acute infection to more than seven months following symptom onset. We show that SARS-CoV-2 is widely distributed, predominantly among patients who died with severe COVID-19, and that virus replication is present in multiple respiratory and non-respiratory tissues, including the brain, early in infection. Further, we detected persistent SARS-CoV-2 RNA in multiple anatomic sites, including throughout the brain, as late as 230 days following symptom onset in one case. Despite extensive distribution of SARS-CoV-2 RNA throughout the body, we observed little evidence of inflammation or direct viral cytopathology outside the respiratory tract. Our data indicate that in some patients SARS-CoV-2 can cause systemic infection and persist in the body for months.

22 August 2022 in JCI Insight
Verified
Journal Article
Open access
PDF file
CCCarmelo Carmona-Rivera
Carmelo Carmona-Rivera
YZYu Zhang
Yu Zhang
KDKerry Dobbs
Kerry Dobbs
TMTovah E. Markowitz
Tovah E. Markowitz
CDClifton Dalgard
Clifton Dalgard
MKMariana J. Kaplan
Mariana J. Kaplan
Dysregulation in neutrophil extracellular trap (NET) formation and degradation may play a role in the pathogenesis and severity of COVID-19; however, its role in the pediatric manifestations of this disease, including multisystem inflammatory syndrome in children (MIS-C) and chilblain-like lesions (CLLs), otherwise known as “COVID toes,” remains unclear. Studying multinational cohorts, we found that, in CLLs, NETs were significantly increased in serum and skin. There was geographic variability in the prevalence of increased NETs in MIS-C, in association with disease severity. MIS-C and CLL serum samples displayed decreased NET degradation ability, in association with C1q and G-actin or anti-NET antibodies, respectively, but not with genetic variants of DNases. In adult COVID-19, persistent elevations in NETs after disease diagnosis were detected but did not occur in asymptomatic infection. COVID-19–affected adults displayed significant prevalence of impaired NET degradation, in association with anti-DNase1L3, G-actin, and specific disease manifestations, but not with genetic variants of DNases. NETs were detected in many organs of adult patients who died from COVID-19 complications. Infection with the Omicron variant was associated with decreased NET levels when compared with other SARS-CoV-2 strains. These data support a role for NETs in the pathogenesis and severity of COVID-19 in pediatric and adult patients.

22 March 2023 in The American Journal of Pathology
Verified
Journal Article
Closed access
HSH. Nida Sen
H. Nida Sen
KVKevin M. Vannella
Kevin M. Vannella
YWYujuan Wang
Yujuan Wang
Joon-Yong ChungJoon-Yong Chung
Joon-Yong Chung
SKShilpa Kodati
Shilpa Kodati
CCChi-Chao Chan
Chi-Chao Chan

1 January 2024 in Annals of Internal Medicine
Verified
Journal Article
Closed access
APAndrew Philip Platt
Andrew Philip Platt
MSManmeet Singh
Manmeet Singh
SSSydney Stein
Sydney Stein
SSShahabuddin Soherwardi
Shahabuddin Soherwardi
EWEmmie de Wit
Emmie de Wit
DCDaniel S. Chertow
Daniel S. Chertow

1 August 2025 in The Journal of Infectious Diseases
Verified
Journal Article
Closed access
HTHeather L Teague
Heather L Teague
SWSeth Warner
Seth Warner
APAndrew Philip Platt
Andrew Philip Platt
SSSydney Stein
Sydney Stein
MRMarcos Javier Ramos-Benitez
Marcos Javier Ramos-Benitez
JSJeffrey R Strich
Jeffrey R Strich
Background: Sepsis is a leading cause of death worldwide. Identifying novel host-directed therapeutic targets may improve sepsis outcomes. Methods: Six nonhuman primates were infected with Klebsiella pneumoniae to induce septic shock and provided supportive care for up to 72 hours. Flow cytometry was used to characterize whole-blood neutrophils (WBNs) and low-density neutrophils (LDNs) at time 0 (T0), T6, T24, and T48 hours postinfection, and postmortem examination (ie, necropsy). Dimensional reduction with clustering via FlowSOM and traditional gating strategies were used to compare WBNs to LDNs and delineate spleen tyrosine kinase (SYK) expression across neutrophils subsets. We measured soluble biomarkers of end-organ dysfunction and neutrophil activation, and quantified SYK and myeloperoxidase in tissue. Results: At T6, we identified populations of active immature WBNs and a population of LDNs not detected at baseline. At T24, neutrophil heterogeneity increased across WBNs and LDNs with differential expression of myeloperoxidase (MPO). Compared to WBNs, LDNs were more activated with increased MPO expression. At T6, SYK expression surged in WBNs and LDNs and SYK+ WBNs and LDNs expressed higher levels of MPO and lactoferrin compared to SYK− neutrophils. Circulating levels of SYK+ LDNs significantly correlated with serum creatinine levels, indicative of acute kidney injury; prolonged prothrombin time and decreased fibrinogen, indicative of consumptive coagulopathy; and SYK expression in tissues. Conclusions: Bacterial sepsis leads to heterogenous populations of circulating neutrophils, including LDNs. Elevated SYK expression in WBNs and LDNs correlates with end-organ dysfunction, highlighting SYK as a potential therapeutic target in bacterial sepsis.

12 July 2023 in Pathogens
Verified
Journal Article
Open access
PDF file
APAndrew Philip Platt
Andrew Philip Platt
BBBenjamin T. Bradley
Benjamin T. Bradley
NNNadia Nasir
Nadia Nasir
SSSydney R. Stein
Sydney R. Stein
SRSabrina Ramelli
Sabrina Ramelli
DCDaniel S. Chertow
Daniel S. Chertow
Bacterial and fungal co-infections are reported complications of coronavirus disease 2019 (COVID-19) in critically ill patients but may go unrecognized premortem due to diagnostic limitations. We compared the premortem with the postmortem detection of pulmonary co-infections in 55 fatal COVID-19 cases from March 2020 to March 2021. The concordance in the premortem versus the postmortem diagnoses and the pathogen identification were evaluated. Premortem pulmonary co-infections were extracted from medical charts while applying standard diagnostic definitions. Postmortem co-infection was defined by compatible lung histopathology with or without the detection of an organism in tissue by bacterial or fungal staining, or polymerase chain reaction (PCR) with broad-range bacterial and fungal primers. Pulmonary co-infection was detected premortem in significantly fewer cases (15/55, 27%) than were detected postmortem (36/55, 65%; p < 0.0001). Among cases in which co-infection was detected postmortem by histopathology, an organism was identified in 27/36 (75%) of cases. Pseudomonas, Enterobacterales, and Staphylococcus aureus were the most frequently identified bacteria both premortem and postmortem. Invasive pulmonary fungal infection was detected in five cases postmortem, but in no cases premortem. According to the univariate analyses, the patients with undiagnosed pulmonary co-infection had significantly shorter hospital (p = 0.0012) and intensive care unit (p = 0.0006) stays and significantly fewer extra-pulmonary infections (p = 0.0021). Bacterial and fungal pulmonary co-infection are under-recognized complications in critically ill patients with COVID-19.